Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

RNS® System Feasibility Study

ClinicalTrials.gov ID: NCT00079781

Public ClinicalTrials.gov record NCT00079781. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 5:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

RNS® System Feasibility Clinical Investigation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The RNS® System is intended to treat patients with medically refractory (hard to treat) epilepsy. The RNS® System Feasibility study is designed to demonstrate safety and evidence of effectiveness of the RNS® System to support the commencement of a pivotal clinical investigation.

Study identification

NCT ID
NCT00079781
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
NeuroPace
Industry
Enrollment
70 participants

Conditions and interventions

Conditions

Interventions

Procedure · Device

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2003
Primary completion
Apr 30, 2006
Completion
Nov 30, 2007
Last update posted
Jan 28, 2014

2004 – 2007

United States locations

U.S. sites
12
U.S. states
11
U.S. cities
11
Facility City State ZIP Site status
Mayo Clinic Scottsdale Phoenix Arizona 85054
Yale University School of Medicine New Haven Connecticut 06520
Mayo Clinic Jacksonville Jacksonville Florida 32224
Medical College of Georgia Augusta Georgia 30912
Rush University Medical Center / Epilepsy Center Chicago Illinois 60612
Louisiana State University Epilepsy Center of Excellence New Orleans Louisiana 70112
Johns Hopkins University School of Medicine Baltimore Maryland 21287
Henry Ford Hospital Detroit Michigan 48202
Mayo Clinic Rochester Rochester Minnesota 55905
Weill Medical College of Cornell University New York New York 10021
Columbia University / Columbia Presbyterian Medical Center New York New York 10032
Swedish Medical Center Seattle Washington 98122

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00079781, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 28, 2014 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00079781 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →